% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Zhu:157007,
author = {J. Zhu and X. Shu and X. Guo and D. Liu and J. Bao and R.
L. Milne and G. G. Giles and C. Wu and M. Du and E. White
and H. A. Risch and N. Malats and E. J. Duell and P. J.
Goodman and D. Li and P. Bracci and V. Katzke$^*$ and R. E.
Neale and S. Gallinger and S. K. Van Den Eeden and A. A.
Arslan and F. Canzian$^*$ and C. Kooperberg and L. E. Beane
Freeman and G. Scelo and K. Visvanathan and C. A. Haiman and
L. Le Marchand and H. Yu and G. M. Petersen and R.
Stolzenberg-Solomon and A. P. Klein and Q. Cai and J. Long
and X.-O. Shu and W. Zheng and L. Wu},
title = {{A}ssociations between {G}enetically {P}redicted {B}lood
{P}rotein {B}iomarkers and {P}ancreatic {C}ancer {R}isk.},
journal = {Cancer epidemiology, biomarkers $\&$ prevention},
volume = {29},
number = {7},
issn = {1538-7755},
address = {Philadelphia, Pa.},
publisher = {AACR},
reportid = {DKFZ-2020-01304},
pages = {1501 - 1508},
year = {2020},
abstract = {Pancreatic ductal adenocarcinoma (PDAC) is one of the most
lethal malignancies, with few known risk factors and
biomarkers. Several blood protein biomarkers have been
linked to PDAC in previous studies, but these studies have
assessed only a limited number of biomarkers, usually in
small samples. In this study, we evaluated associations of
circulating protein levels and PDAC risk using genetic
instruments.To identify novel circulating protein biomarkers
of PDAC, we studied 8,280 cases and 6,728 controls of
European descent from the Pancreatic Cancer Cohort
Consortium and the Pancreatic Cancer Case-Control
Consortium, using genetic instruments of protein
quantitative trait loci.We observed associations between
predicted concentrations of 38 proteins and PDAC risk at an
FDR of < 0.05, including 23 of those proteins that showed an
association even after Bonferroni correction. These include
the protein encoded by ABO, which has been implicated as a
potential target gene of PDAC risk variant. Eight of the
identified proteins (LMA2L, TM11D, IP-10, ADH1B, STOM,
TENC1, DOCK9, and CRBB2) were associated with PDAC risk
after adjusting for previously reported PDAC risk variants
(OR ranged from 0.79 to 1.52). Pathway enrichment analysis
showed that the encoding genes for implicated proteins were
significantly enriched in cancer-related pathways, such as
STAT3 and IL15 production.We identified 38 candidates of
protein biomarkers for PDAC risk.This study identifies novel
protein biomarker candidates for PDAC, which if validated by
additional studies, may contribute to the etiologic
understanding of PDAC development.},
cin = {C020 / C055},
ddc = {610},
cid = {I:(DE-He78)C020-20160331 / I:(DE-He78)C055-20160331},
pnm = {313 - Cancer risk factors and prevention (POF3-313)},
pid = {G:(DE-HGF)POF3-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:32439797},
pmc = {pmc:PMC7334065},
doi = {10.1158/1055-9965.EPI-20-0091},
url = {https://inrepo02.dkfz.de/record/157007},
}